Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM8002 (BNT327) + Chemotherapy in First-Line Metastatic Colorectal Cancer
NCT07133750Phase 2Recruiting
- Sponsor
- Biotheus
- Start
- Aug 2025
- Primary completion
- May 2027
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pumitamig in colorectal cancer (CRC), sponsored by Biotheus. Started Aug 2025; status: recruiting.
02
Drugs
pumitamig
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07133750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07133750.